Trident Texofab Board of Directors
Get the latest insights into the leadership at Trident Texofab. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mr. Hardik Jigishkumar Desai | Chairman & Managing Director |
| Mr. Chetan Chandrakant Jariwala | Whole Time Director |
| Mr. Manish Dhirajlal Halwawala | Executive Director |
| Mr. Mishal Shailesh Patel | Ind. Non-Executive Director |
| Mrs. Ankita Jignesh Saraiya | Ind. Non-Executive Director |
| Mrs. Natasha Karbhari | Ind. Non-Executive Director |
Trident Texofab Share price
TTFL
250.2
5.95 (2.44%)Last updated on 4 Sep, 2025 | 15:29 IST
BUYSELL
Today's High
250.20
Today's Low
244.00
52 Week Low
42.05
52 Week High
259.00
The current prices are delayed, login to your account for live prices
LoginTrident Texofab FAQs
The board at Trident Texofab consists of experienced professionals, including Mr. Hardik Jigishkumar Desai , Mr. Chetan Chandrakant Jariwala , and others, overseeing the company’s strategic and corporate governance.
Directors at Trident Texofab are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mr. Hardik Jigishkumar Desai is the current chairman at Trident Texofab.
Executive directors at Trident Texofab are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Trident Texofab adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Trident Texofab, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.